Admission to Trading on Euronext Brussels
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN…
Month: February 2021
Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference
LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) — Enochian BioSciences, a company focused on gene-modified…
Indus Holdings to Present at the Benzinga Virtual Cannabis Capital Conference Feb. 25 and 26
Online event will examine present and future of California’s growing cannabis market and the role…
Atreca to Participate at Upcoming Virtual Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL),…
Altimmune To Announce Year End 2020 Financial Results on February 25, 2021
GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
Travere Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Bright Minds Biosciences Inc. Announces Marketed Public Offering
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR…
Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical…
GENFIT: new market research data highlight potential of elafibranor in PBC
Insights from Pr. Sven Francque and Dr. Kris V. Kowdley on PBC, a chronic, cholestatic,…
GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis
CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading…
ImmuCell Makes Important Regulatory Submission and Announces Unaudited Financial Results for the Year Ended December 31, 2020
PORTLAND, Maine , Feb. 22, 2021 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”),…
Plus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
– Positive interim data through cohort five for the ReSPECT™ Phase 1 clinical trial in…
Opiant Pharmaceuticals to Report Fourth Quarter 2020 Financial Results and Host Conference Call and Webcast on March 4, 2021
SANTA MONICA, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a…
Celldex Therapeutics to Expand Development of CDX-0159 into Prurigo Nodularis (PN)
–Dermatological indication characterized by chronic, intensely itchy nodules; mast cell activation believed to play an…
FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50%
FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with…
Adverum to Host Conference Call and Webcast to Highlight Updated ADVM-022 Development Plans in Wet AMD, Recent Business Progress, and Fourth Quarter 2020 Financial Results
Key Opinion Leader Arshad M. Khanani, M.D., M.A., director of clinical research, Sierra Eye Associates,…
MatriSys Announces Positive Results From a Phase I Study of MSB-0221 for the Topical Treatment of Atopic Dermatitis
– Study Reveals the Potential of Beneficial Bacteria to Treat Chronic Skin Diseases – LA…
Axiom Presents “Innovating Direct-to-Patient Trials: How to use effective eClinical Solutions to enhance the success of your clinical studies” at Outsourcing in Clinical Trials West Coast 2021
SAN FRANCISCO, Feb. 22, 2021 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of…